Modified cold sore virus injected to fight disfiguring skin tumors
NCT ID NCT07102394
Summary
This early-stage study is testing whether a modified virus (IMLYGIC) can be safely injected into skin tumors caused by neurofibromatosis type 1 (NF1) to shrink them. The virus is designed to infect and destroy tumor cells. Researchers will enroll 10 adults with NF1 who have at least 8 small, measurable skin tumors to see if the treatment is feasible and tolerable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NF1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.